Colonoscopy and stool tests more effective and cost‐effective than novel blood‐based screening tests

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, findings show that the effectiveness of blood‐based screening tests eroded substantially as the follow‐up rate with colonoscopy decreased. Also, patients treated with immune checkpoint inhibitors have an increased risk of developing psoriasis, and more evidence is available on the benefits of HIPEC for recurrent ovarian cancer.